Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genasense Phase III Melanoma Trial Gets Green Light

Apr 01 2008

• By Emily Hayes

Related Content

Medarex/Bristol Plan To File Ipilimumab For Metastatic Melanoma Despite Phase II Failure

Dec 11 2007

Genta Returns To Old Territory With New Genasense Study

Apr 18 2007

FDA Clears Path For Genta’s Genasense In Chronic Lymphocytic Leukemia

Mar 17 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window